VANCOUVER, BC – Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that the Company’s President and Chief Executive Officer, Dr. Mark Murray, will present a corporate overview at the Rodman & Renshaw Annual Global Investment Conference on Thursday September 10, 2009 at 4:05 pm ET at the New York Palace Hotel in New York City. A live webcast of the presentation will be available and can be accessed on the Company’s website, http://www.tekmirapharm.com/.

Dr. Murray will also participate in a panel discussion on RNAi Therapeutics at the Rodman & Renshaw conference taking place Thursday September 10, 2009 at 8:25 am ET.

About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at http://www.tekmirapharm.com/. Tekmira is based in Vancouver, B.C.

Contact Information for Tekmira Pharmaceuticals Corporation

Investors
Adam Peeler
The Equicom Group
Phone: 416-815-0700 x 225
Email: apeeler@equicomgroup.com

Ian Mortimer
Executive Vice President and Chief Financial Officer
Phone: 604-419-3200

Media
David Ryan
Longview Communications Inc.
Phone: 604-694-6031
Email: dryan@longviewcomms.ca